Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06504485Recruiting

Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment

Role: collaborator

NCT07031557Active Not Recruiting

Pregnancy and Lactation- Associated Osteoporosis

Role: lead

NCT05793970Unknown

IL6 on Umbilical Cord (Evaluation of IL-6 Levels on Umbilical Cord)

Role: lead

NCT05138094Not ApplicableUnknown

LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection

Role: collaborator

NCT04829032Unknown

GOODBYE HARTMANN TRIAL: 100 YEARS OF HARTMANN'S PROCEDURE

Role: lead

NCT03720093Completed

Exploratory Analysis of Pulmonary Microbiome in Intubated Patients

Role: collaborator

NCT02381054Completed

Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients

Role: collaborator

All 7 trials loaded